Back to Directory
Last Updated: 09/06/2026

Newcleic

Bristol
Founded 2023
Cell-free enzymatic synthesis platform for biotherapeutic discovery

Newcleic is a biotech developing cell-free, enzymatic synthesis methods and systems to accelerate biotherapeutic discovery and manufacture.

The platform uses cell-extracted or purified enzymatic machinery to produce proteins and nucleic acids from genetic templates without the need for live cell engineering, enabling faster design-build-test cycles.

Applications include antibody-drug conjugates, RNA therapeutics, and other biologics where rapid, cell-free production offers manufacturing and discovery advantages.

Company Notes